Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-25-112229

Options or other derivatives

  • Director acquired 366,000 shares (grant or award)
  • Director returned 366,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Ganjei James Kelly · Director

Table II: Derivative

16 lines
Date Transaction Shares Owned after D/I
2025-11-18 Returned to the company : show line 1 in the form Stock Option (right to buy) −108,000 0 D
2025-11-18 Grant or award : show line 2 in the form Stock Option (right to buy) +108,000 108,000 D
2025-11-18 Returned to the company : show line 3 in the form Stock Option (right to buy) −108,000 0 D
2025-11-18 Grant or award : show line 4 in the form Stock Option (right to buy) +108,000 108,000 D
2025-11-18 Returned to the company : show line 5 in the form Stock Option (right to buy) −15,975 0 D
2025-11-18 Grant or award : show line 6 in the form Stock Option (right to buy) +15,975 15,975 D
2025-11-18 Returned to the company : show line 7 in the form Stock Option (right to buy) −19,025 0 D
2025-11-18 Grant or award : show line 8 in the form Stock Option (right to buy) +19,025 19,025 D
Loading xslF345X05/ownership.xml…